TMS Armadale

TMS Armadale: Advanced Mental Health Care with Neuralia TMS

Transcranial Magnetic Stimulation (TMS) is transforming mental health treatment in Australia, making proven therapies accessible to more people than ever before. At Neuralia TMS Armadale, patients in Western Australia can benefit from this non-invasive brain stimulation technology in a local, purpose-built clinic. Here's what you need to know about TMS Armadale, how it works, who it helps, and what to expect from your journey.

TMS Armadale Overview

Delivers Transcranial Magnetic Stimulation (TMS), a non-invasive brain stimulation therapy for mental health and neurological conditions

TMS Armadale brings evidence-based, non-invasive treatment options to patients experiencing depression and other neurological conditions. This therapy uses magnetic fields to stimulate nerve cells in the brain, offering new avenues for those not responding adequately to medication. It's particularly helpful for patients struggling with treatment-resistant depression, anxiety disorders, and certain neurological complaints like chronic pain.

Located at 1/273 Railway Avenue, Armadale, Western Australia 6112

Conveniently situated on Railway Avenue, TMS Armadale is readily accessible for residents of Armadale and neighbouring regional areas. The clinic is housed in a modern facility with ample parking, making visits straightforward and stress-free.

Part of the Neuralia TMS network, a leading TMS provider in Western Australia

Neuralia TMS is recognised for its commitment to safety, scientific rigour, and compassionate care. The Armadale location upholds these standards as part of a broader network across WA, ensuring consistent, high-quality TMS care no matter where you seek treatment.

Represents expansion of accessible mental health treatment to regional areas outside Perth's CBD

Historically, advanced mental health interventions were often limited to Perth's central metro clinics. Neuralia TMS Armadale broadens the options available in the southeast, bridging critical gaps in regional mental health access.

What is Transcranial Magnetic Stimulation (TMS)?

Uses high-strength magnetic fields to stimulate nerve cells in the brain

TMS applies strong, focused magnetic pulses to the surface of the scalp, delivering energy through the skull to activate nerve cells involved in mood regulation and other functions.

Delivers magnetic pulses to specific brain areas, promoting neuroplasticity through long-term potentiation (LTP) and long-term depression (LTD)

Through repeated stimulation, TMS can change the activity level of targeted brain regions, especially those linked with depression and other psychiatric disorders. By harnessing LTP and LTD, TMS promotes neuroplasticity, helping the brain form and strengthen new neural pathways.

Primarily targets the dorsolateral prefrontal cortex (DLPFC) for depression treatment

For depression, the left DLPFC is usually the primary target as numerous studies show this area is underactive in people experiencing depressive symptoms.

Encourages formation of new neural connections and rewiring of brain circuits

This approach helps re-establish healthier patterns of mood regulation, with lasting benefits for many patients.

Magnetic coil placed on scalp generates focused magnetic field

A small coil is placed directly on the patient's scalp over the treatment area, precisely targeting the brain circuits involved.

Induces electrical currents in neurons, causing depolarization and action potentials

These magnetic pulses safely induce electrical activity in neurons, prompting them to fire and communicate more effectively.

Session duration approximately 20 minutes

A standard TMS session typically lasts around 20 minutes from start to finish.

Treatment frequency five times per week for 7-8 weeks (typical 35-session course)

Most patients attend daily sessions Monday to Friday over roughly 7-8 weeks, a protocol validated by robust clinical evidence.

Patients remain awake and alert during treatment

There's no need for anaesthesia or sedation, and patients remain fully awake, relaxed, and able to return to daily activities immediately after each session.

Historical Development

Michael Faraday discovered electromagnetic induction principles in 1881

The foundation for TMS dates to Faraday's discoveries in electromagnetism, enabling the creation of devices that use magnetic fields to influence electrical activity.

Anthony Barker and colleagues developed the first TMS device in 1985

The modern TMS device was invented in the UK, setting the stage for global clinical research into its therapeutic uses.

1990s saw significant clinical trials confirming depression treatment potential

Early clinical trials established that TMS could lead to improvements in mood for people with depression, sparking widespread interest.

FDA approved for treatment-resistant depression in 2008

TMS received a major boost with this US approval, which followed strong evidence for its safety and effectiveness.

Listed on Medicare Benefits Schedule in November 2021 in Australia

In a significant step for access, Australia added TMS to its Medicare Benefits Schedule, meaning eligible patients may access subsidised treatment.

FDA approvals expanded to OCD in 2018, anxious depression in 2021

With growing data, regulatory bodies have since recognised TMS for treating obsessive-compulsive disorder and anxious depression.

TMS Technology Types

Standard/Repetitive TMS (rTMS) uses Figure-8 coil design

This is the most common TMS method, using a coil shaped to direct the field precisely to target regions.

Reaches approximately 1.5-2.5 centimetres into the brain

The figure-8 coil stimulates surface-level cortical areas, which is optimal for mood-related interventions.

Focuses on cortical brain areas, primarily the dorsolateral prefrontal cortex

Most protocols target the DLPFC due to its key role in emotional processing.

Session length 19-37 minutes depending on protocol

Depending on frequency and pulse intensity, session times can vary slightly to optimise effectiveness and safety.

Deep TMS (dTMS) uses specialised H-coil technology

Deep TMS can penetrate further, reaching deeper brain structures that may be involved in tougher-to-treat symptoms.

Can reach 3-4 centimetres or more into the brain

This H-coil design focuses the magnetic field more broadly and deeply.

Stimulates both superficial and deeper brain structures

That may provide benefits in certain disorders beyond standard depression protocols.

Theta Burst Stimulation (TBS) mimics brain's natural firing patterns

TBS delivers rapid-fire bursts of pulses, reflecting the brain's own rhythms.

Delivers three pulses at 50Hz repeated every 200 milliseconds

This high-frequency protocol is relatively new but shows promise in enhancing efficiency and effect.

Produces stronger neuroplastic changes than traditional TMS

TBS protocols can lead to quicker and possibly more robust brain adaptations.

Conditions Treated at TMS Armadale

Major Depressive Disorder - most well-established and researched indication

TMS is highly effective for individuals with persistent depressive symptoms who've tried at least two antidepressant medications without adequate relief.

Particularly effective for patients who failed two or more antidepressants

Patients with treatment-resistant depression have been found to respond well to TMS, experiencing substantial symptom improvements.

50-60% response rates, with 30-35% achieving full remission

These outcomes are supported by leading clinical trials and real-world data from Neuralia's patient cohorts.

Obsessive-Compulsive Disorder (OCD) targets anterior cingulate cortex

TMS protocols for OCD differ from depression, sometimes involving deeper brain targets associated with compulsive thought patterns.

30% remission rates and 55% clinically significant improvement

Results for OCD are promising, with significant reductions in symptom severity achieved in a substantial subset of patients.

Post-Traumatic Stress Disorder (PTSD) reduces hypervigilance, anxiety, and flashbacks

Though less common than for depression and OCD, TMS can help patients experiencing chronic symptoms of trauma.

Generalised Anxiety Disorder (GAD) - highly effective treatment option

TMS is emerging as a solid option for treatment-resistant generalised anxiety, leading to marked improvements in day-to-day anxiety and worry.

50% of patients experienced anxiety symptom reductions after 20+ sessions

Over half of GAD patients at clinics like TMS Armadale report improved anxiety levels partway through their treatment course.

Additional conditions include chronic pain, Parkinson's disease symptoms, tinnitus, addiction disorders, ADHD

While these indications are less established, emerging research and clinics like Neuralia offer hope to patients whose options have previously been limited.

Clinical Effectiveness and Outcomes

Depression response rates 29-54% achieve at least 50% symptom improvement

Data from local and international trials confirm up to half of patients achieve noticeable improvements in depression scores.

Remission rates 19-20% at end of treatment course

One in five or more patients with depression experience full remission of symptoms.

Treatment-resistant subgroup shows 38.1% response rate and 58.3% clinical improvement

For those who don't respond to medication, TMS may represent a turning point, offering both response and measurable functional improvement.

Improvements begin within one week of treatment initiation

Some patients notice brighter mood and improved sleep just days after starting TMS.

Most patients maintain improvements for 6 months or longer

Sustained results are possible, particularly when treatment is followed up with ongoing mental health support.

OCD remission approximately 30% of patients

Nearly a third of OCD patients see a marked reduction in intrusive symptoms.

OCD clinical improvement 55% show clinically significant improvements

This means more than half see enough change to improve day-to-day functioning.

Anxiety reduction 50% experience symptom reduction after 20+ sessions

Similar effect sizes are seen in patients undergoing TMS for generalised anxiety, helping to restore emotional balance.

Treatment Process at TMS Armadale

Free consultation with no-obligation assessment to determine TMS suitability

The Armadale clinic offers a complimentary, confidential assessment for new patients, a chance to discuss potential benefits and address questions.

GP or psychiatrist referral necessary for Medicare-eligible patients

Eligible patients should secure a referral, which helps determine funding for their TMS course under the Medicare scheme.

Comprehensive psychiatric evaluation, medical history, failed treatment documentation

The clinical team reviews your psychiatric history, medication response records, and overall medical background to ensure TMS is a safe and suitable option.

TMS mapping session determines precise treatment coordinates and optimal stimulation parameters

An initial mapping session personalises the treatment so every session reaches the right brain area at the optimal intensity.

Psychiatrist identifies target brain area (typically left DLPFC for depression)

Your psychiatrist will identify which part of your brain should be targeted for maximum clinical benefit.

Motor threshold determination finds minimum magnetic field intensity

The team tests to find just how much energy is needed to achieve therapeutic stimulation with maximum comfort.

Approximately 20 minutes per session

Each treatment visit is relatively quick and rarely disrupts your day.

5 sessions per week for 7-8 weeks (typically 35 sessions total)

You'll attend five times a week, with flexibility to discuss scheduling challenges.

Recliner seating with ability to relax, watch TV, or converse

The environment is designed for patient comfort, most patients read, relax, or chat with staff during sessions.

No anaesthesia or sedation required

There's no recovery period needed, so you're free to get on with your plans for the day.

Patients can drive, work, or exercise immediately after

Driving, work, or other routine activities can resume straight after your session.

Safety Profile and Side Effects

Headache most frequent side effect, affecting 20-36% of patients

Headaches are the most commonly reported side effect but are generally mild and short-lived.

Application site pain reported in 36% of active treatment patients

Scalp discomfort or tenderness may be felt around the area where the coil sits.

Mild tingling or tapping feeling on scalp

Most patients describe the sensation during treatment as harmless tapping or tingling.

Dizziness/lightheadedness reported in 2-3% of patients

Rarely, patients may feel slightly lightheaded, but this resolves quickly.

Headaches and scalp pain typically diminish after first week of treatment

As patients adjust to treatment, these effects usually lessen or disappear.

Seizures extremely rare, occurring in 0.08-0.1 per 1000 treatment sessions

TMS has a very low risk of serious complications, especially compared to other brain stimulation methods.

No cognitive impairment unlike ECT

Unlike electroconvulsive therapy, TMS doesn't impact your memory or thinking skills.

No memory loss or cognitive side effects

Clinical trials have failed to show any long-term cognitive risks from TMS.

Adverse events generally mild and manageable

Most side effects, if present, are short-lived and do not interfere significantly with daily functioning.

Much safer than antidepressants (no weight gain, sexual dysfunction) and ECT

TMS is not associated with weight gain, sexual dysfunction, or hormone changes, making it an excellent alternative for sensitive patients.

Medicare Coverage and Eligibility

Major depressive disorder diagnosis required

Current Medicare provisions require a diagnosis of major depression to access subsidised TMS care.

Age requirement 18 years or older

TMS funding through Medicare is limited to adult patients.

Must have trialled at least two antidepressants or cannot tolerate medication

Eligibility requires prior antidepressant use, or an inability to take medication due to significant side effects.

Psychological therapy attempted if appropriate

Medicare may check that alternative treatments like talk therapy have been tried where suitable.

Not previously received TMS treatment

The first course is covered for those new to TMS. Relapsed patients may be eligible for a reduced number of sessions.

Medicare coverage began November 1, 2021

This represents a significant breakthrough in equitable access to advanced depression therapies.

Up to 35 treatment sessions covered initially

Most patients can have their entire first treatment course fully covered.

Up to 15 sessions covered for re-treatment due to relapse

Patients whose symptoms return after initial success can access additional subsidised sessions.

Some private insurers cover portion of TMS sessions

Depending on your policy, extra support for ongoing or non-Medicare-eligible sessions may be available.

Private rates $100-$145 per session for self-funding patients

For those ineligible or without private health cover, session fees are competitive for the region.

TMS Armadale - Neuralia Network Details

Email neuralia.armadale@gmail.com

Patients and GPs can reach the clinic directly for enquiries or referrals at this email address.

State-of-the-art facility equipped with latest TMS technology

The Armadale centre uses up-to-date, high-precision TMS equipment for reliable and effective treatment.

Wheelchair accessible facilities with accessible bathrooms

Accessibility for all patients is assured, including ramp access and compliant bathrooms.

Ample parking provided

Onsite parking is free and located close to the entrance for patient convenience.

Highly trained clinicians and compassionate nursing staff

The TMS Armadale team is made up of dedicated professionals trained specifically in TMS delivery and patient care.

Clinical Team

Dr Shanek Wick FRANZCP psychiatrist and Medical Director of Neuralia TMS

A specialist psychiatrist, Dr Shanek Wick, leads the team and shapes its clinical standards.

Certification in TMS and tDCS through International Clinical TMS Society and Neurocare

Dr Wick's additional qualifications show a commitment to evidence-based neurostimulation practice.

Trained at UWA and Fremantle Hospital

Dr Wick's background brings a blend of academic training and practical experience to Neuralia's Armadale clinic.

Focus on Neurostimulation and Addiction Psychiatry

Neuralia's clinical staff are equipped to manage complex neuropsychiatric conditions beyond depression and anxiety.

Highly trained nurses in TMS administration and patient care

A skilled nursing team ensures smooth, safe treatment from consultation through completion.

Dr Jon Laugharne over 20 years experience, special interest in TMS and trauma

Bringing decades of experience to his patients, Dr Laugharne strengthens the clinic's trauma-informed care.

Dr Stephen Proud involved in regional TMS services

His role supports delivery of TMS to patients outside the metro area.

Dr Ajay Singh contributing psychiatrist to Neuralia network

Another key psychiatrist, Dr Singh, supports both consultation and ongoing patient care.

Patient Experience

Patients report significant quality of life improvements

Many patients share stories of increased energy, restored optimism, and improved functioning following TMS at Armadale.

Some report TMS more effective than multiple antidepressants

Patients who had little or no relief from medications often say TMS made a greater impact.

Improvements in depression, anxiety, pain, and ADHD symptoms reported

A wide array of conditions have responded to treatment, with patients noting substantive change.

Consistent praise for welcoming, professional, and caring staff

The clinical and nursing teams are frequently noted for their compassionate approach and ability to ease the treatment process.

Most patients report minimal or manageable side effects

Common feedback shows headaches or mild scalp sensations generally fade quickly.

Some patients report mood improvements by third or fifth session

Early benefits are often noticed, although best results typically emerge after the full treatment course.

Potential 4+ month waits reported by some patients

Occasional high demand may mean waiting for an initial appointment, if considering TMS, reach out early.

Regular 5-day-per-week requirement challenging for working patients

It's wise for prospective patients to plan for the treatment schedule and seek work or family support as needed.

Comparison with Other Treatments

TMS avoids medication-related weight gain, sexual dysfunction, emotional blunting

TMS's lack of systemic side effects makes it an attractive option, not least for those sensitive to medications.

Response rates comparable to antidepressants (50-60%)

TMS matches the efficacy of many drug-based therapies, but without their risks or inconveniences.

No medication conflicts or polypharmacy complications

Patients with complex prescriptions or health conditions can access TMS without worrying about drug interactions.

No withdrawal symptoms or medication tolerance development

Stopping TMS does not cause physical withdrawal, so it can be started or stopped without tapering.

Often used alongside psychotherapy for enhanced outcomes

Many patients benefit most when they continue talking therapies alongside TMS.

Simultaneous rTMS and psychotherapy shows 66% response and 56% remission rates

Research shows a powerful synergy when these treatments are combined in trusted clinics like TMS Armadale.

Requires no anaesthesia or hospitalisation unlike ECT

The simplicity of the treatment process supports short clinic visits and a easy transition back to normal life.

Does not impair memory or cognitive function like ECT

TMS helps preserve a clear mind, another reason it is increasingly preferred for sensitive patients.

Research Evidence and Scientific Support

Over 90 completed clinical trials supported 2008 FDA approval

Robust, peer-reviewed research lies behind every TMS device in clinical use today.

Over 35 years of evidence-based research supporting TMS efficacy

Longstanding academic work underpins clinical confidence in TMS as a safe, effective intervention.

Multiple systematic reviews and meta-analyses confirm effectiveness

Large summaries of global data consistently point to TMS as a reliable tool for refractory depression and other mental health challenges.

Extensive studies confirm TMS-induced synaptic plasticity

Scientists have observed both the short- and long-term brain changes that support symptom improvement.

Research shows TMS increases brain-derived neurotrophic factor levels

This key growth factor is critical for neuron health and highlights why TMS helps restore emotional balance.

Studies document LTP and LTD mechanisms underlying TMS effects

Ongoing basic science supports the "rewiring" effects attributed to TMS, giving patients and clinicians confidence in its mechanisms.

Accelerated TMS protocols showing promise

Emerging data suggest faster, more intensive treatments may further cut down time to benefit.

Ongoing research to predict individual treatment response

Scientists are working on new tools to help clinicians match patients to precise protocols most likely to work for them.

Practical Considerations for Patients

Secure GP or psychiatrist referral for Medicare eligibility

Referrals are essential for accessing subsidised care and for coordinated communication between your care team members.

Compile records of previous antidepressant trials

Having a history of medication responses ready can streamline your intake and assessment.

Book free initial consultation to assess suitability

Neuralia TMS Armadale offers a no-charge first session to clarify if TMS is right for you.

Plan for 5 sessions per week over 7-8 weeks

The standard treatment schedule can be demanding, so consider work flexibility and transport options during this time.

Consider work schedule flexibility during treatment course

Some find it helpful to discuss options with their employer or seek flexibility for the duration of their course.

Regular trips to Armadale clinic required

Consistent attendance boosts the likelihood of a robust treatment response.

Can drive to/from appointments with no recovery time needed

Leave time for the session, but there's no need for lifts or post-treatment downtime.

Over-the-counter pain relievers can prevent headaches

Simple remedies like paracetamol can help manage common, mild headaches.

Expect side effects to diminish after first week

Any initial discomfort usually fades quickly as your body adjusts.

Use provided earplugs to protect hearing

You'll be offered earplugs to dampen the clicking sound produced by the device and support your comfort.

About Neuralia TMS

Business: Neuralia TMS Armadale

Director: Dr. Shanek Wick

Phone: 08 6243 0346

Email: info@neuralia.com.au

Website: www.neuraliatms.com.au

Location: 1/273 Railway Avenue, Armadale, Western Australia, 6112

Frequently Asked Questions about TMS Armadale

What is TMS therapy at TMS Armadale?

TMS therapy at TMS Armadale is a non-invasive brain stimulation treatment that uses magnetic fields to stimulate nerve cells, primarily for depression and certain neurological and psychiatric conditions. It's delivered in a comfortable, purpose-built clinic in Armadale, WA, and is suitable for patients who haven't responded to traditional treatments.

Who is eligible for TMS treatment at TMS Armadale?

Eligibility for TMS Armadale includes adults (18 years or older) diagnosed with major depressive disorder who have not responded to at least two antidepressant medications or cannot tolerate them, and have tried psychological therapies if appropriate. A GP or psychiatrist referral is needed for Medicare-subsidised treatment.

What conditions are treated at TMS Armadale?

TMS Armadale treats major depressive disorder, obsessive-compulsive disorder (OCD), generalised anxiety disorder (GAD), post-traumatic stress disorder (PTSD), chronic pain, and certain neurological issues like Parkinson's symptoms and tinnitus. Depression and anxiety are the most common indications at the clinic.

Is TMS therapy at TMS Armadale safe and are there any side effects?

TMS therapy at TMS Armadale is considered very safe. The most common side effects are mild headaches or scalp discomfort, which usually decrease after the first week. Serious side effects like seizures are extremely rare, and TMS does not cause cognitive or memory impairment.

How long does a typical TMS treatment course take at TMS Armadale?

At TMS Armadale, a typical treatment course involves 35 sessions over 7–8 weeks, with five sessions per week. Each session lasts about 20 minutes and patients can resume normal activities, including driving or working, immediately afterward.

What is the cost of TMS Armadale and is it covered by Medicare?

TMS Armadale is eligible for Medicare coverage if you meet specific criteria, covering up to 35 initial sessions. Private rates range from $100 to $145 per session if you’re not eligible for Medicare. Some private insurers may partially cover the costs.